BPG is committed to discovery and dissemination of knowledge
Number of total visits
410160
Number of visits today
86
Number of downloads
118335
MEMBERSHIP
Cited by in F6Publishing
Number
Citing Articles
1
Li L , Zhang F , Liu Z , Fan Z . Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome. Cancers (Basel) 2023;15 . [PMID: 36612317 DOI: 10.3390/cancers15010321 ] [ Reference Citation Analysis ]
2
Liu H , Wen Z , Chen H , Yang Z , Le Z , Liu Z , Chen Y , Liu L . Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels. J Control Release 2022;352 :497-506. [PMID: 36341931 DOI: 10.1016/j.jconrel.2022.10.053 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
3
Hooda-nehra A , L. Smith T, I. Ferrer A, I. Staquicini F, Arap W, Pasqualini R, Rameshwar P. Targeted Regulation and Cellular Imaging of Tumor-Associated Macrophages in Triple-Negative Breast Cancer: From New Mechanistic Insights to Candidate Translational Applications. Macrophages celebrating 140 years of discovery [Working Title] 2022. [DOI: 10.5772/intechopen.105654 ] [ Reference Citation Analysis ]
4
Carter ME , Koch A , Lauer UM , Hartkopf AD . Clinical Trials of Oncolytic Viruses in Breast Cancer. Front Oncol 2021;11 :803050. [PMID: 35004328 DOI: 10.3389/fonc.2021.803050 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 2 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
